Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.

Objective: Cholinergic therapy is used in mild-to-moderate Alzheimer’s disease (AD) and antiglutamatergic therapy in moderate-to-severe AD. Global scales, as commonly used in clinic